Products Affected - Description
10,000 unit multiple-dose vial, single count (NDC 55566-1501-01)
10,000 unit multiple-dose vial, single count (NDC 00052-0315-10)
Chorionic gonadotropin (human) injection, Fresenius Kabi
10,000 unit multiple-dose vial, 10 count (NDC 63323-0025-10)
Reason for the Shortage
Merck states their product is on allocation to prevent use in the gray market.
Insufficient supplies for usual ordering.
Estimated Resupply Dates
- Fresenius Kabi has chorionic gonadotropin injection on back order and the company estimates a release date in mid-July 2015. Check your wholesaler for availability.
- Ferring is releasing Novarel injection regularly to direct order customers.
- Merck has Pregnyl injection on allocation. Place orders through your wholesaler.
July 13, April 10, March 2 and 23, February 13 and January 12, 2015; November 19, September 22, July 25, July 14, July 9, June 16, May 12, March 31, March 17, February 24, January 15, January 6, 2014; October 21, August 8, May 30, March 8, 2013; December 10, September 27, August 1, June 15, May 16, March 12, February 24, 2012; December 21, October 27, September 13, July 22, May 10, March 22, February 16, 2011; December 17, October 13, August 23, July 20, June 8, April 22, March 2, February 17, January 25, 2010; December 9, November 6, October 2, September 21, August 25, July 23, June 15, May 18, April 24, March 23, February 20, January 9, 2009; November 3, October 6, August 25, July 28, June 2, May 5, April 8, February 21, January 29, 2008, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins